CLINICAL_TRIALS
trial_result
· 2017-05-08
Clinical Trial Update: Efficacy of Adjuvant Mitotane Treatment (ADIUVO) [Phase 3]
Summary
Phase 3 trial ADIUVO evaluating adjuvant mitotane for adrenocortical carcinoma; the update notes the trial status as UNKNOWN.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: University of Turin, Italy | Conditions: Adrenocortical Carcinoma | Phase 3 | Status: UNKNOWN